Trial Profile
A Trial to Compare the Effects on Respiratory Function of Sugammadex and Neostigmine in the Reversal of Moderate Rocuronium-induced Neuromuscular Blockade
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Neostigmine (Primary) ; Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 02 Mar 2016 New trial record